A Phase 3b/4 Randomized, Open-label, Efficacy Assessor-Blinded Study, to Evaluate the Efficacy and Safety of Upadacitinib for the Treatment of Adult Subjects with Moderate to Severe Atopic Dermatitis (AD) and Inadequate Response to Dupilumab (SWITCH-UP) Read more about A Phase 3b/4 Randomized, Open-label, Efficacy Assessor-Blinded Study, to Evaluate the Efficacy and Safety of Upadacitinib for the Treatment of Adult Subjects with Moderate to Severe Atopic Dermatitis (AD) and Inadequate Response to Dupilumab (SWITCH-UP)
Implantation Mycoses in Immunocompromised Patients: a retrospective review of disease course and treatment efficacy Read more about Implantation Mycoses in Immunocompromised Patients: a retrospective review of disease course and treatment efficacy
A Pilot Study of Rimegepant in Moderate Plaque-type Psoriasis Read more about A Pilot Study of Rimegepant in Moderate Plaque-type Psoriasis
